China s Kintor faced a temporary
setback as interim analysis for a late-stage trial for its
potential COVID-19 pill did not yield sufficient data due to the
lack of hospitalised cases, sending its. | December 28, 2021
(Bloomberg) Where will newly developed Covid pills be needed the most? Rather than pandemic hot spots, it’ll be a place where the virus has yet to gain a sustained foothold: China.
That’s the take from Tong Youzhi, chief executive officer at Kintor Pharmaceutical Ltd.
BEIJING (Bloomberg): Where will newly developed Covid pills be needed the most? Rather than pandemic hot spots, it’ll be a place where the virus has yet to gain a sustained foothold: China.
Where will newly developed Covid pills be needed the most? Rather than pandemic hot spots, it'll be a place where the virus has yet to gain a sustained foothold: China.